Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study

NCT01221753 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Due to slow accrual

Conditions

Squamous Cell Carcinoma of the Head and Neck
Human Papilloma Virus

Interventions

DRUG: docetaxel
DRUG: cisplatin
DRUG: 5-FU
RADIATION: IMRT
DRUG: cetuximab
DRUG: carboplatin

Sponsor

Dana-Farber Cancer Institute